Please try another search
For the nine months ended 30 September 2015, CTTPharmaceutical Holdings Inc revenues was not reported. Netloss increased from $46K to $1M. Higher net loss reflectsConsulting fees increase from $0K to $537K (expense),Investor relations increase from $0K to $369K (expense),Professional fees increase from $31K to $80K (expense).Basic Earnings per Share excluding Extraordinary Itemstotaled to -$0.05.
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -0.34 | -0.36 | -0.34 | -0.63 |
Net Income | -0.34 | -0.36 | -0.34 | -0.63 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Assets | 0.92 | 1.18 | 1.42 | 1.66 |
Total Liabilities | 0.18 | 0.16 | 0.21 | 0.17 |
Total Equity | 0.74 | 1.03 | 1.21 | 1.49 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.08 | -0.07 | -0.04 | -0.07 |
Cash From Investing Activities | 0 | 0.15 | ||
Cash From Financing Activities | 0.03 | 0.03 | 0.03 | |
Net Change in Cash | -0.05 | -0.04 | -0.01 | 0.08 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review